← SynDRA
HYDROXYPROGESTERONE
SynDRA canonical compound SYN0003477 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | PGR |
| Mechanism of action | progesterone receptor agonist |
| Indication | spontaneous preterm birth |
| Disease area | obstetrics/gynecology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Delalutin (TN)
- Proluton depot (TN)
- NSC 15468
- Pregn-4-ene-3,20-dione, 17-hydroxy-
- U 3096
- Prodix
- Prodox
- Gestageno gador
- Gestageno
- Hidroxiprogesterona
- Hydroxyprogesteronum
- Pregn-4-ene-3,20-dione-17-ol
- delta(4)-Pregnene-17alpha-ol-3,20-dione
- Idrossiprogesterone
- alpha Hydroxy progesterone
- CHEBI:17252
- DTXCID4020747
- RefChem:55376
- Setaderm
- Oxiprogesteronum
- Idrossiprogesterone [DCIT]
- Hydroxyprogesteronum [INN-Latin]
- Hidroxiprogesterona [INN-Spanish]
- MFCD00003659
- HSDB 3343
- 4-Pregnen-17a-ol-3,20-dione
- MLS000028453
- MLS001076300
- 4-Pregnen-17alpha-ol-3,20-dione
- Delta4-Pregnen-17alpha-ol-3,20-dione
- NCGC00093949-03
- alpha-17Hydroxypregn-4-ene-3,20-dione
- SMR000058349
- Hydroxyprogesterone (INN)
- (9beta)-17-Hydroxypregn-4-Ene-3,20-Dione
- HYDROXYPROGESTERONE [INN]
- CAS-68-96-2
Reported adverse events
- Cervical incompetence
- Headache
- Infection
- Injection site pain
- Injection site pruritus
- Nausea
- Oligohydramnios
- Pregnancy
- Pruritus
- Rash
- Stillbirth
- Urinary tract infection
Look up HYDROXYPROGESTERONE in the interactive SynDRA portal →